Applied Biosystems removes the bias from gene expression analysis
Applied Biosystems (ABI) has developed a sequencing-based tool for gene expression analysis that can detect even minute amounts of previously unknown RNA transcripts.
Oxford Diffraction goes ‘SuperNova’
Oxford Diffraction has launched a new dual wavelength X-ray diffractometer that promises to determine the structure of molecules in even the most challenging of crystal samples.
Controlling the quality of protein datasets
Hungarian researchers have developed a new bioinformatics tool that can identify and correct abnormal, incorrect and mispredicted protein annotations in public databases.
New research takes the bite out of the stem cell debate
Japanese scientists have derived ‘embryonic’ stem cells from tissue taken from discarded human wisdom teeth, potentially bypassing the ethical dilemma of taking them from embryos.
Boehringer hooks up with Chinese API firm
Boehringer Ingelheim has formed a strategic production alliance with Chinese manufacturer Hisoar, significantly expanding its worldwide API network.
Codexis and Arch prepare for generic Lipitor market
Codexis and Arch Pharmalabs’ expanded supply and development deal will see the latter produce APIs used in the manufacture of atorvastatin, principal component of Pfizer’s cholesterol buster Lipitor.
Israeli court rules against “disingenuous” Taro
The Tel-Aviv District Court has found in favour of Sun Pharmaceuticals in its long running struggle to acquire Israeli drug and pharmaceutical ingredient maker Taro Pharmaceutical Industries.
FDA warns Sandoz on unvalidated manufacturing
The FDA says that Sandoz, the generics arm of Swiss drug major Novartis, failed to validate manufacturing processes used to produce metoprolol succinate ER tablets at its plant in Wilson, North Carolina.
Equateq bullish about lipid API market
A facility operated by fatty acid specialist Equateq on the island of Lewis in Scotland has met with UK good manufacturing practice (GMP) standards for the production of lipid-based APIs for the drug industry.
Pharma manufacturing: people on the move
in-PharmaTechnologist.com presents its latest round-up of personnel changes in the pharmaceutical sector.
Second Daytrana recall as liner problems continue
Shire and Noven have voluntarily withdrawn batches of the ADHD drug Daytrana for the second time in 12 months due to ongoing problems with the product’s release liner.
Pharma manufacturing products: news in brief
in-PharmaTechnologist.com’s latest round up of products launched in the pharmaceutical manufacturing sector includes new offerings from innovatis, Stäubli, GE and Sterilin.
Daewoong to sell Eurand’s cyclobenzaprine ER
Drug delivery specialist Eurand is to begin supplying its extended release formulation of cyclobenzaprine HCl to South Korea’s Daewoong Pharmaceuticals.
Funding imminent for versatile drug delivery tech
NanoBio is believed to be on the verge of securing funding to continue developing its NanoStat drug delivery platform.
FDA seizes drugs worth $74,000
The US Food and Drug Administration (FDA) has ordered the seizure of $74,000 worth of Xiadafil VIP tablets after SEI Pharmaceuticals refused to withdraw them from the market.